05-05-2020
danielfela / shutterstock.com
US customs authorities have seized tens of thousands of counterfeit and unapproved COVID-19 test kits, largely sent through the postal system, since the beginning of the pandemic.
Life Sciences Intellectual Property Review (LSIPR) tracks the increasing challenges for intellectual property specialists in the rapidly evolving world of life sciences. From gene patents to stem cell research, we provide the very best news and analysis.
To continue reading this article and to access 4,500+ articles, our digital magazines and special reports published for LSIPR subscribers only then you will need a subscription.
If you are already subscribed please login.
Official LSIPR subscribers include:
Allen & Overy
Arnold & Siedsma
Birch, Stewart, Kolasch & Birch LLP (BSKB)
Carpmaels & Ransford
Cooley
European Patent Office
Finnegan LLP
GH Research
Gowling WLG
George Washington Law School
HGF Limited
IQVIA
Kirkland & Ellis International LLP
Marks & Clerk
Mintz Levin
NiKang Therapeutics Inc.
Powell Gilbert LLP
Procopio, Cory, Hargreaves & Savitch LLP
Taylor Wessing
The United States Patent and Trademark Office (USPTO)
Valea AB
World Intellectual Property Office
For multi-user price options, or to check if your company has an existing subscription we can add you into for FREE, please contact Atif at achoudhury@newtonmedia.co.
If you have any technical issues please email tech support.
COVID-19, counterfeit, Xanax, test kits, CBP, customs, Cincinnati, postal system, DHL, O'Hare's International Mail Facility
US agencies to work together against COVID-19 fakes
03-11-2020
US customs seize ‘astonishing’ amount of counterfeit COVID-19 masks
08-10-2020
USPTO temporarily allows online plant patent filings
07-05-2020
Pfizer, Alibaba, Amazon, Merck unite to fight COVID-19 fraud
06-05-2020
OECD and Europol issue COVID-19 counterfeits warning
22-04-2020
